These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Vaccination with DNA encoding internal proteins of influenza virus does not require CD8(+) cytotoxic T lymphocytes: either CD4(+) or CD8(+) T cells can promote survival and recovery after challenge. Epstein SL, Stack A, Misplon JA, Lo CY, Mostowski H, Bennink J, Subbarao K. Int Immunol; 2000 Jan; 12(1):91-101. PubMed ID: 10607754 [Abstract] [Full Text] [Related]
3. Dose-dependent changes in influenza virus-infected dendritic cells result in increased allogeneic T-cell proliferation at low, but not high, doses of virus. Oh S, McCaffery JM, Eichelberger MC. J Virol; 2000 Jun; 74(12):5460-9. PubMed ID: 10823850 [Abstract] [Full Text] [Related]
4. Mechanism of protective immunity against influenza virus infection in mice without antibodies. Epstein SL, Lo CY, Misplon JA, Bennink JR. J Immunol; 1998 Jan 01; 160(1):322-7. PubMed ID: 9551987 [Abstract] [Full Text] [Related]
6. Influenza A subtype cross-protection after immunization of outbred mice with a purified chimeric NS1/HA2 influenza virus protein. Mbawuike IN, Dillion SB, Demuth SG, Jones CS, Cate TR, Couch RB. Vaccine; 1994 Nov 25; 12(14):1340-8. PubMed ID: 7856302 [Abstract] [Full Text] [Related]
7. Antigen-specific CD8(+) T cells persist in the upper respiratory tract following influenza virus infection. Wiley JA, Hogan RJ, Woodland DL, Harmsen AG. J Immunol; 2001 Sep 15; 167(6):3293-9. PubMed ID: 11544317 [Abstract] [Full Text] [Related]
8. Induction of CD8+ cytotoxic T cells by immunization with killed influenza virus and effect of cholera toxin B subunit. Mbawuike IN, Wyde PR. Vaccine; 1993 Sep 15; 11(12):1205-13. PubMed ID: 7903015 [Abstract] [Full Text] [Related]
10. Self-adjuvanting influenza candidate vaccine presenting epitopes for cell-mediated immunity on a proteinaceous multivalent nanoplatform. Szurgot I, Szolajska E, Laurin D, Lambrecht B, Chaperot L, Schoehn G, Chroboczek J. Vaccine; 2013 Sep 13; 31(40):4338-46. PubMed ID: 23880363 [Abstract] [Full Text] [Related]
11. Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T cell responses. Bender A, Bui LK, Feldman MA, Larsson M, Bhardwaj N. J Exp Med; 1995 Dec 01; 182(6):1663-71. PubMed ID: 7500011 [Abstract] [Full Text] [Related]
12. CD40 ligand preferentially modulates immune response and enhances protection against influenza virus. Hashem AM, Gravel C, Chen Z, Yi Y, Tocchi M, Jaentschke B, Fan X, Li C, Rosu-Myles M, Pereboev A, He R, Wang J, Li X. J Immunol; 2014 Jul 15; 193(2):722-34. PubMed ID: 24928989 [Abstract] [Full Text] [Related]
13. Mucosal administration of raccoonpox virus expressing highly pathogenic avian H5N1 influenza neuraminidase is highly protective against H5N1 and seasonal influenza virus challenge. Kingstad-Bakke B, Kamlangdee A, Osorio JE. Vaccine; 2015 Sep 22; 33(39):5155-62. PubMed ID: 26271828 [Abstract] [Full Text] [Related]
14. Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase. Epstein SL, Misplon JA, Lawson CM, Subbarao EK, Connors M, Murphy BR. J Immunol; 1993 Jun 15; 150(12):5484-93. PubMed ID: 8390536 [Abstract] [Full Text] [Related]
15. Vaccine molecules targeting Xcr1 on cross-presenting DCs induce protective CD8+ T-cell responses against influenza virus. Fossum E, Grødeland G, Terhorst D, Tveita AA, Vikse E, Mjaaland S, Henri S, Malissen B, Bogen B. Eur J Immunol; 2015 Feb 15; 45(2):624-35. PubMed ID: 25410055 [Abstract] [Full Text] [Related]
16. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells. Shibolet O, Alper R, Zlotogarov L, Thalenfeld B, Engelhardt D, Rabbani E, Ilan Y. Int J Cancer; 2003 Aug 20; 106(2):236-43. PubMed ID: 12800200 [Abstract] [Full Text] [Related]
17. CD4+ and CD8+ T cells exhibit differential requirements for CCR7-mediated antigen transport during influenza infection. Heer AK, Harris NL, Kopf M, Marsland BJ. J Immunol; 2008 Nov 15; 181(10):6984-94. PubMed ID: 18981118 [Abstract] [Full Text] [Related]
18. Dendritic cells and CD28 costimulation are required to sustain virus-specific CD8+ T cell responses during the effector phase in vivo. Dolfi DV, Duttagupta PA, Boesteanu AC, Mueller YM, Oliai CH, Borowski AB, Katsikis PD. J Immunol; 2011 Apr 15; 186(8):4599-608. PubMed ID: 21389258 [Abstract] [Full Text] [Related]
19. Nasal-associated lymphoid tissues (NALTs) support the recall but not priming of influenza virus-specific cytotoxic T cells. Pizzolla A, Wang Z, Groom JR, Kedzierska K, Brooks AG, Reading PC, Wakim LM. Proc Natl Acad Sci U S A; 2017 May 16; 114(20):5225-5230. PubMed ID: 28461487 [Abstract] [Full Text] [Related]
20. Dendritic Cells Targeting Lactobacillus plantarum Strain NC8 with a Surface-Displayed Single-Chain Variable Fragment of CD11c Induce an Antigen-Specific Protective Cellular Immune Response. Liu J, Yang G, Huang H, Shi C, Gao X, Yang W, Zhang Z, Liu Y, Xu K, Wang J, Kang Y, Jiang Y, Wang C. Infect Immun; 2020 Jan 22; 88(2):. PubMed ID: 31740528 [Abstract] [Full Text] [Related] Page: [Next] [New Search]